Knockdown of GPRC5B alleviates the high glucose-induced inflammation and extracellular matrix deposition of podocyte through inhibiting NF-κB pathway
Main Article Content
Keywords
diabetes, diabetic nephropathy (DN), high glocuse (HG), GPRC5B, ECM deposition, NF-κB pathway
Abstract
Background: Diabetes is a serious disease that could greatly increase the risk of cardiovascular complications, whereas the underlying pathology of DN is still unknown. GPRC5B is a member of the RAIG subfamily of type 3 (family C) GPCR, and its role in DN is still unclear.
Objective: To unveil the role of GPRC5B in diabetic nephropathy (DN) progression and investigate the potential signaling pathway.
Materials and methods: Podocytes were stimulated with high glucose and expression of GPRC5B was analyzed by qPCR and western blot. Then the level of GPRC5B was depleted by siRNA transfection and inflammatory cytokine level was monitored by ELISA assay. The ECM depostion and the activation of NF-κB pathway were detected by Immunoblot.
Results: We investigated the possible role of GPRC5B in the pathology of diabetic nephropathy. We found GPRC5B was highly expressed in high glocuse (HG) induced podocytes. The depletion of GPRC5B inhibited HG induced cell inflammation. In addition, the ablation of GPRC5B suppressed the HG induced ECM deposition. We further found GPRC5B could alleviate the inflammation and extracellular matrix deposition of HG-induced podocytes through NF-κB pathway.
Conclusion: We therefore thought GPRC5B could serve as a promising target for the treatment of diabetic nephropathy. G-protein-coupled receptors.
References
2. Lin Y, Shao Z, Zhao M, Li J, Xu X. PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy. Biochem Biophys Res Commun. 2021;550:62–9. 10.1016/j.bbrc.2020.12.030
3. Kim KH, Hong GL, Jung DY, Karunasagara S, Jeong WI, Jung JY. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice. Mol Med. 2021;27(1):25. 10.1186/s10020-021-00285-4
4. Chen J, Gu X, Zhou L, Wang S, Zhu L, Huang Y, et al. Long non-coding RNA-HOTAIR promotes the progression of sepsis by acting as a sponge of miR-211 to induce IL-6R expression. Experiment Ther Med. 2019;18(5):3959–67. 10.3892/etm.2019.8063
5. Wu M, Yang Z, Zhang C, Shi Y, Han W, Song S, et al. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Metab Clin Experiment. 2021;118:154748. 10.1016/j.metabol.2021.154748
6. Huang C, Zhou Y, Huang H, Zheng Y, Kong L, Zhang H, et al. Islet transplantation reverses podocyte injury in diabetic nephropathy or induced by high glucose via inhibiting RhoA/ROCK/NF-kappaB signaling pathway. J Diabetes Res. 2021;2021:9570405. 10.1155/2021/9570405
7. Alonso-Gardon M, Elorza-Vidal X, Castellanos A, La Sala G, Armand-Ugon M, Gilbert A, et al. Identification of the GlialCAM interactome: the G protein-coupled receptors GPRC5B and GPR37L1 modulate megalencephalic leukoencephalopathy proteins. Human Mol Genet. 2021;30(17):1649–65. 10.1093/hmg/ddab155
8. Soni A, Amisten S, Rorsman P, Salehi A. GPRC5B a putative glutamate-receptor candidate is negative modulator of insulin secretion. Biochem Biophy Res Commun. 2013;441(3):643–8.
9. Carvalho J, Chennupati R, Li R, Gunther S, Kaur H, Zhao W, et al. Orphan G protein-coupled receptor GPRC5B controls smooth muscle contractility and differentiation by inhibiting prostacyclin receptor signaling. Circulation. 2020;141(14):1168–83. 10.1161/CIRCULATIONAHA.119.043703
10. Zhong H, Hao L, Li X, Wang C, Wu X. Anti-inflammatory role of trilobatin on lipopolysaccharide-induced acute lung injury through activation of AMPK/GSK3β-Nrf2 pathway. Signa Vitae. 2020;16(2):160–6.
11. Desai N, Koppisetti H, Pande S, Shukla H, Sirsat B, Ditani AS, et al. Nanomedicine in the treatment of diabetic nephropathy. Future Med Chem. 2021;13(7):663–86. 10.4155/fmc-2020-0335
12. Wetzel MD, Stanley K, Maity S, Madesh M, Bopassa JC, Awad AS. Homoarginine ameliorates diabetic nephropathy independent of nitric oxide synthase-3. Physiol Rep. 2021;9(5):e14766. 10.14814/phy2.14766
13. Wang L, Wang P, Li X, Dong Y, Wu S, Xu M, et al. Combination CTLA-4 immunoglobulin treatment and ultrasound microbubble-mediated exposure improve renal function in a rat model of diabetic nephropathy. Aging. 2021;13(6):8524–40. 10.18632/aging.202664
14. Tan Y, Cao H, Li Q, Sun J. The role of transcription factor Ap1 in the activation of the Nrf2/ARE pathway through TET1 in diabetic nephropathy. Cell Biol Internat. 2021;45(8). 10.1002/cbin.11599
15. Takizawa N, Hironaka T, Mae K, Ueno T, Horii Y, Nagasaka A, et al. GPRC5B promotes collagen production in myofibroblasts. Biochem Biophy Res Commun. 2021;561:180–6. 10.1016/j.bbrc.2021.05.035
16. Kohyama-Koganeya A. Regulation of energy metabolism by BOSS/GPRC5B. Seikagaku J Jap Biochem Soc. 2017;89(1): 98–101.
17. Kim YJ, Sano T, Nabetani T, Asano Y, Hirabayashi Y. GPRC5B activates obesity-associated inflammatory signaling in adipocytes. Sci Signal. 2012;5(251):ra85. 10.1126/scisignal.2003149
18. Kurabayashi N, Nguyen MD, Sanada K. The G protein-coupled receptor GPRC5B contributes to neurogenesis in the developing mouse neocortex. Development. 2013;140(21):4335–46. 10.1242/dev.099754
19. Sano T, Kohyama-Koganeya A, Kinoshita MO, Tatsukawa T, Shimizu C, Oshima E, et al. Loss of GPRC5B impairs synapse formation of Purkinje cells with cerebellar nuclear neurons and disrupts cerebellar synaptic plasticity and motor learning. Neurosci Res. 2018;136:33–47. 10.1016/j.neures.2018.02.006
20. Mu G, Deng Y, Lu Z, Li X, Chen Y. miR-20b suppresses mitochondrial dysfunction-mediated apoptosis to alleviate hyperoxia-induced acute lung injury by directly targeting MFN1 and MFN2. Acta Biochim Biophys Sin (Shanghai). 2021;53(2):220–8. 10.1093/abbs/gmaa161
21. Wang DL, Dai WY, Wang W, Wen Y, Zhou Y, Zhao YT, et al. Interfering RNA against PKC-alpha inhibits TNF-alpha-induced IP3R1 expression and improves glomerular filtration rate in rats with fulminant hepatic failure. Am J Renal Physiol. 2018;314(5):F942–55. 10.1152/ajprenal.00433.2016
22. Ma YM, Peng YM, Zhu QH, Gao AH, Chao B, He QJ, et al. Novel CHOP activator LGH00168 induces necroptosis in A549 human lung cancer cells via ROS-mediated ER stress and NF-kappaB inhibition. Acta Pharmacol Sinica. 2016;37(10):1381–90. 10.1038/aps.2016.61
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.